The effect of tenoxicam on intraperitoneal adhesions and prostaglandin E2 levels in mice

Anesthesia and Analgesia

Volumn 88, Issue 4, 1999, Pages 939-942

  Celebioglu, Bilge ^b   Eslambouli, Nima Ramzi ^b   Olcay, Ekmel ^b   Atakan, Şafak ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Department of Anesthesiology ^*

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; KETAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PROSTAGLANDIN E2; SODIUM CHLORIDE; STEROID; TENOXICAM;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG EFFICACY; HISTOPATHOLOGY; INFERTILITY; INTESTINE INJURY; INTESTINE OBSTRUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LAPAROTOMY; MOUSE; NONHUMAN; PELVIS PAIN SYNDROME; PERITONEUM ADHESION; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0032924117     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199904000-00048     Document Type: Article

References (24)

1. Yilmazlar T, Kaya E, Gürpinar E, Emiroǧlu H. Efficacy of tenoksikam on intraabdominal adhesion prevention in a rat model. J Intern Med Res 1996;24:352-7.
2. Ar'rajab A, Mileski W, Sentementes JA. The role of neutrophils in peritoneal adhesion formation. J Surg Res 1996;61:143-6.
3. Bradshaw D, Castin CH, Kennedy AJ, Roberts NA. Pharmacological and biochemical activities of tenoxicam a new non-steroidal anti-inflammatory drug. Agents Actions 1984;15: 569-77.
4. Elhakim M, Nafie M. I.V. tenoxicam for analgesia during caesarean section. Br J Anaesth 1995;74:643-6.
5. Puccetti G, Galassi A, Gigli P, et al. Iontophoresis of tenoxicam in the therapy of osteoarthrosis. Clin Ther 1992;140:239-42.
6. Taglieri G, Raffaele A, Dalessandro E, et al. Evaluation of the anti-inflammatory effect and tolerability of tenoxicam in short time treatment of osteoarthrosis in the aged. Clin Ther 1992;140: 243-9.
7. Nilsen OG. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet 1994;26:16-43.
8. Knudsen KE, Brofeldt S, Mikkelsen S, et al. Peritonsillar infiltration with low dose tenoxicam after tonsillectomy. Br J Anaesth 1995;75:286-8.
9. Troconiz I, Lopez Bustamante LG, Fos L. Tenoxicam pharmacokinetics in rats. J Pharm Sci 1995;84:1482-7.
10. Nair SK, Bbhat IK, Aura AL. Role of proteolytic enzymes in the prevention of postoperative intraperitoneal adhesion. Arch Surg 1974;108:849-53.
11. Thomson JN, Whawell SA. Pathogenesis and prevention of adhesion formation. Br J Surg 1995;82:3-5.
12. Gilmore N, Vane JR, Wylline JH. Prostaglandine release by the spleen. Nature 1968;218:1135-40.
13. Vane JR. A sensitive method for the assay of 5-hydroxy thriptamine. Br J Pharmacol 1957;12:344-9.
14. Hasçelik G, Şener B, Hasçelik Z. Effect of some anti-inflammatory drugs on human neutrophil chemotaxis. J Int Med Res 1994;22:100-6.
15. Menzies D. Postoperative adhesions: their treatment and relevance in clinical practice. Ann R Coll Surg Engl 1993;75:147-53.
16. Walker AP, Condon RE. Peritonitis and intraabdominal abscesses. In: Schwartz SI, eds. Principles of surgery. New York: McGraw-Hill, 1989:1459-90.
17. Schwartz SI, Ellis H. Adhesions and bands. In: Schwartz SI, Ellis H, eds. Maingot's abdominal operations. New York: Appleton & Lange, 1990:919-23.
18. Gazzanigea AB, James JM, Shobe JB, Ippenhiem EB. Prevention of peritoneal adhesions in the rat. Arch Surg 1975;110:429-32.
19. Holtz G. Prevention and management of peritoneal adhesions. Fertil Steril 1984;41:497-507.
20. Replogle RL, Jhonson R, Gross RE. Prevention of postoperative intestinal adhesions with combined promethazine and dexamethasone therapy. Ann Surg 1966;163:580-91.
21. Grosfeld JL, Berman IR, Sciller M, Morse T. Excessive morbidity resulting from the prevention of intestinal adhesions with steroids and antihistamines. J Pediatr Surg 1973;8:221-34.
22. Kapur BML, Talwar JF, Gulasti SM. Oxyphenbutazone: antiinflammatory agent in prevention of peritoneal adhesions. Arch Surg 1969;98:301-9.
23. Gonzales JP, Todd PA. Tenoxicam: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1987;34:289-310.
24. Coughey D, Waterworth RF. A study of the safety of tenoxicam in general practices. N Z Med J 1989;102:582-3.